Mutual Pharmaceutical
As of the edition of 20 October 2026, Mutual Pharmaceutical runs 4 drugs, 3 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 3 |
| Stopped | 1 |
| Total | 4 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Metronidazole | none listed | 0 |
| Fenofibric acid | none listed | 1 |
| Quinine | none listed | 0 |
A route B row is one company at one target.